Contrast Media

Product Details:

Urografin 60% Injection is used as a diagnostic agent. It is a dye used in various imaging tests (like X-ray, angiography, etc.) to visualize certain body parts.

It is injected into the body following which it coats the organs like stomach and esophagus, making it easy to visualize the organs in X-ray or CT-scan examinations. This injection is given under the supervision of a healthcare professional.

Product Details:

LIPIODOL ULTRA FLUID is a diagnostic agent. It belongs to the class of iodinated contrast agents used for radiological examinations. LIPIODOL ULTRA FLUID is used to enhance the contrast of the images obtained during these radiological examinations, which improves the visualisation and outline of certain body parts.

Product Details:

Ultravist 300mg I/ml Injection is known as a contrast agent. It is injected into the body before an X-ray test or CT scan to enhance the visibility of internal body structures like blood vessels and non-bony structures.

Ultravist 300mg I/ml Injection is administered by a healthcare professional in a hospital and clinical setting. This medicine should not be self-administered.

The most common side effects of this medicine include headache, nausea, injection site reactions, vasodilatation, vomiting, back pain, frequent urge to urinate, chest pain, taste change, and abnormal vision. If you experience any of this side effect and it bothers you, let your doctor know.

Product Details:

Gadavist is a gadolinium-based contrast agent indicated for intravenous use in diagnostic magnetic resonance imaging (MRI) in adults and children (2 years of age and older) to detect and visualize areas with disrupted blood brain barrier (BBB) and/or abnormal vascularity of the central nervous system.

Product Details:

Magnevist (gadopentetate dimeglumine) is a contrast agent that has magnetic properties. It is used in combination with magnetic resonance imaging (MRI) to allow blood vessels, organs, and other non-bony tissues to be seen more clearly on the MRI.

Product Details:

OMNISCAN (gadodiamide) Injection is the formulation of the gadolinium complex of diethylenetriamine pentaacetic acid bismethylamide, and is an injectable, nonionic extracellular enhancing agent for magnetic resonance imaging. OMNISCAN is administered by intravenous injection.

OMNISCAN is provided as a sterile, clear, colorless to slightly yellow, aqueous solution. Each 1 mL contains 287 mg gadodiamide and 12 mg caldiamide sodium in Water for Injection. The pH is adjusted between 5.5 and 7.0 with hydrochloric acid and/or sodium hydroxide. OMNISCAN contains no antimicrobial preservative. OMNISCAN is a 0.5 mol/L solution of aqua[5,8-bis(carboxymethyl)11-[2-(methylamino)-2-oxoethyl]-3-oxo-2,5,8,11-tetraazatridecan-13-oato (3-)-N⁵, N⁸, N¹¹, O³, O⁵, O⁸, O¹¹, O¹³] gadolinium hydrate, with a molecular weight of 573.66 (anhydrous), an empirical formula of C₁₆H₂₈GdN₅O₉•xH₂O, and the following structural formula:

Product Details:

VISIPAQUE™ (iodixanol) Injection, 5,5´-[(2-hydroxy-1,3-propanediyl)bis (acetylimino)] bis[N,N´-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3- benzenedicarboxamide], is a dimeric, isosmolar, nonionic, water-soluble, radiographic contrast medium with a molecular weight of 1550.20 (iodine content 49.1%). It is administered by intravascular injection.

VISIPAQUE Injection is provided as a ready-to-use sterile, pyrogen-free, colorless to pale yellow solution, in concentrations of 270 and 320 mg of organically bound iodine per mL (550 and 652 mg of iodixanol per mL, respectively). Sodium chloride and calcium chloride have been added, resulting in an isotonic solution for injection.

VISIPAQUE 270 (270 mgI/mL) contains 0.074 mg calcium chloride dihydrate per mL and 1.87 mg sodium chloride per mL, and VISIPAQUE 320 (320 mgI/mL) contains 0.044 mg calcium chloride dihydrate per mL and 1.11 mg sodium chloride per mL, providing for both concentrations a sodium/calcium ratio equivalent to blood. In addition, each milliliter contains 1.2 mg tromethamine and 0.1 mg edetate calcium disodium. The pH is adjusted to 7.4 with hydrochloric acid and/or sodium hydroxide to achieve a range between pH 6.8 and 7.7 at 22°C. All solutions are terminally sterilized by autoclaving and contain no preservatives. The two concentrations of VISIPAQUE Injection (270 mgI/mL and 320 mgI/mL) have the following physical properties: